Edge lifting observed during stability pull – CAPA documentation failure


Published on 03/01/2026

Investigation of Edge Lifting Observed During Stability Pull in Transdermal Patches

In the pharmaceutical manufacturing sector, ensuring the quality and integrity of products is paramount. A recent incident involving edge lifting observed during a stability pull of transdermal patches has raised significant concerns regarding manufacturing defects. This article provides a comprehensive framework for investigating this anomaly, including clear steps for identifying root causes, data collection strategies, and effective CAPA documentation.

After reading this article, pharmaceutical professionals will gain insights into conducting thorough investigations specifically for edge lifting issues, along with actionable steps to establish corrective and preventive actions, ensuring compliance with regulatory expectations from authorities such as the FDA, EMA, and MHRA.

Symptoms/Signals on the Floor or in the Lab

Edge lifting in transdermal patches is observable during routine stability testing. Symptoms may include:

  • Visual evidence of lifting at the edges of the patch.
  • Temperature variations affecting adhesive strengths.
  • Discoloration at the lifting edges that
may indicate degradation.
  • Customer complaints about adherence following application.
  • These symptoms are critical indicators suggesting a potential issue with the product’s stability or manufacturing process. Early identification of these signals can mitigate larger, systemic issues and enhance product reliability.

    Likely Causes

    When investigating edge lifting, it is essential to categorize the potential causes. The following categories should be assessed:

    Category Possible Causes
    Materials Inadequate adhesive properties, wrong polymer selection, or expired raw materials.
    Method Improper application techniques or inadequate curing time.
    Machine Equipment malfunction or improper settings during manufacturing.
    Man Operator errors in application or failure to follow SOPs.
    Measurement Inaccuracies in measuring adhesive thickness or environmental factors.
    Environment Changes in humidity or temperature affecting adhesive performance.

    Immediate Containment Actions (first 60 minutes)

    Upon detection of edge lifting during stability pulls, immediate actions must be initiated to contain the issue:

    1. Isolate affected batches and halt distribution to prevent external consumer exposure.
    2. Conduct a visual inspection to determine the extent of edge lifting across different samples.
    3. Document findings and create a deviation report, noting the symptoms and timing of the observations.
    4. Inform cross-functional teams (Quality Control, Production, and Regulatory Affairs) of the issue.
    5. Initiate a risk assessment to evaluate impact on patient safety and regulatory compliance.

    Investigation Workflow

    The investigation workflow should be methodical and comprehensive. Key steps include:

    1. **Data Collection**: Gather stability data, batch records, production logs, and any previous OOS or complaints associated with the batch.
    2. **Trend Analysis**: Look for patterns in data that could indicate chronic issues (e.g., repeated edge lifting across batches).
    3. **Interviews**: Engage with operators and quality personnel to identify any notable deviations from expected procedures during production.
    4. **Document Review**: Examine SOPs related to production and testing processes to ensure compliance.
    5. **Testing**: Conduct further testing on retained samples to assess various conditions (temperature, humidity) affecting patch performance.

    It is critical to interpret the findings considering both qualitative and quantitative aspects to draw accurate conclusions.

    Root Cause Tools

    Numerous analytical tools are available to assist in pinpointing root causes:

    • **5-Why Analysis**: A straightforward questioning technique to delve deeper into causal factors. For instance, if edge lifting occurred due to an adhesive failure, you ask “why?” five times to explore the underlying cause.
    • **Fishbone Diagram (Ishikawa)**: Useful for categorizing causes in a visual manner (Materials, Method, Machine, etc.), allowing teams to systematically explore potential defects.
    • **Fault Tree Analysis**: This deductive reasoning approach helps visualize potential fault pathways leading to edge lifting, perfect for complex problems.

    Select the tool based on the complexity of the situation; simpler cases may benefit from the 5-Why analysis, while multi-faceted issues could warrant a fault tree approach.

    CAPA Strategy

    To effectively resolve the edge lifting issue, a robust CAPA plan must be developed:

    • Correction: Address the immediate issue (e.g., cease distribution of affected patches and quarantine them).
    • Corrective Action: Identify and implement solutions (e.g., reformulate adhesive, revise manufacturing SOPs).
    • Preventive Action: Develop a monitoring plan and enhance training to prevent recurrence, including additional checks after the stability pull.

    Ensure all actions taken are documented with evidence to comply with regulatory audits and be prepared for follow-up assessments.

    Control Strategy & Monitoring

    A control strategy is critical to maintain product integrity following the CAPA implementation:

    • Statistical Process Control (SPC): Implement SPC to monitor critical parameters during production that affect adhesive properties.
    • Real-time Trending: Utilize data analytics tools to detect deviations before they become major issues.
    • Sample Testing: Regularly test patches for adhesion performance under various environmental conditions to ensure stability over time.
    • Alarm Systems: Establish alarms for critical environmental factors that could affect product quality.

    Verification steps must be added to gauge the effectiveness of the CAPA actions taken and ensure adherence to sound quality principles throughout the lifecycle of the product.

    Validation / Re-qualification / Change Control Impact

    Any changes made following an investigation may necessitate additional validation or re-qualification processes. Consider the following:

    Related Reads

    • Assess whether reformulations or new materials involved require fresh validation studies.
    • Document changes in applicable change control systems, ensuring that all stakeholders are informed.
    • Reassess manufacturing processes to incorporate any new controls and validation protocols.

    Inspection Readiness: What Evidence to Show

    In preparation for potential regulatory inspections, it is critical that companies maintain comprehensive and well-organized records:

    • Deviation reports detailing symptoms, findings, and all investigation activity.
    • Batch records showing compliance with production procedures.
    • Quality control logs that illustrate the history of the product and testing results leading up to the stability pull.
    • CAPA documentation outlining corrections, actions taken, and effectiveness checks.

    Ensure that every interaction and action taken is well-documented, as this evidence is crucial for regulatory review.

    FAQs

    What is edge lifting in transdermal patches?

    Edge lifting refers to the separation of the patch material from the skin or backing layer, which can compromise adherence and drug delivery.

    What could cause edge lifting?

    Possible causes include insufficient adhesive quality, environmental factors like humidity or temperature, and manufacturing errors.

    How should I document a deviation for edge lifting?

    Document any findings in a deviation report, including symptoms, root cause analysis, and corrective actions taken.

    What are the regulatory implications of edge lifting?

    Edge lifting could potentially lead to non-compliance with product specifications and, depending on severity, could require reporting to regulatory agencies.

    What is the best tool for root cause analysis?

    The best tool depends on the situation; the 5-Why technique is great for simpler issues, while Fishbone diagrams are better for complex, multifactorial problems.

    How often should stability testing be conducted?

    Stability testing frequency depends on regulatory requirements and product specifications but is typically performed at defined intervals throughout the product lifecycle.

    What kind of training should operators receive to prevent edge lifting?

    Training should cover proper application techniques, equipment operation, and awareness of environmental conditions that impact product integrity.

    Can CAPA processes be integrated with existing quality management systems?

    Yes, CAPA processes should be integrated into the quality management system to ensure consistency and compliance with regulatory standards.

    Are there standards for transdermal patch manufacturing?

    Yes, transdermal patch manufacturing must comply with GMP guidelines as set out by organizations like the FDA, EMA, or other regulatory bodies.

    What documentation assures inspection readiness?

    Maintain comprehensive records including deviation reports, batch records, CAPA documentation, quality control logs, and validated processes.

    What is the role of SPC in manufacturing transdermal patches?

    SPC helps monitor processes in real-time to identify trends and prevent defects, thereby ensuring consistent product quality.

    How do I handle customer complaints related to edge lifting?

    Log complaints in the quality management system, initiate investigations, and implement corrective actions as necessary, ensuring to communicate with affected customers.

    Pharma Tip:  Residual solvent OOS during patch manufacturing – inspection finding risk